European Trade Union Institute, ETUI.

Accueil > Topics > Health & Safety - working conditions > News list > Endocrine disruptors cost the US 310 billion euros a year

News list

20 October 2016

Endocrine disruptors cost the US 310 billion euros a year

Researchers estimate the United States economy takes a €310 billion hit annually as endocrine-disrupting compounds lower IQs, increase behavior problems and exacerbate health problems like obesity and diabetes.

That’s more than twice the annual estimated cost of €148 billion in the European Union, where regulations may limit exposure to some of these chemicals, researchers note in The Lancet Diabetes and Endocrinology.

The researchers estimated total costs linked to these chemicals based on both the direct cost of treatment and the indirect cost of lost productivity or earnings. Then, they compared the U.S. results to findings from a previous study done in Europe.

Costs are higher in the U.S. in large part due to widespread use of a chemical mixture (polybrominated diphenyl ether, PBDE) applied to furniture to make it less flammable that has been restricted in Europe since 2008. Sources: Reuters, Environmental Health News

Read more:

Attina TM, et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis, The Lancet Diabetes & Endocrinology, 17 October 2016

All news